Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

BACKGROUND: Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard adjuvant therapy in patients with stage III colon cancer. However, since oxaliplatin is associated with cumulative neurotoxicity, a shorter duration of therapy could spare toxic effe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:N Engl J Med
Autors principals: Grothey, A., Sobrero, A.F., Shields, A.F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., Meyerhardt, J.A., Vernerey, D., Yamanaka, T., Boukovinas, I., Meyers, J.P., Renfro, L.A., Niedzwiecki, D., Watanabe, T., Torri, V., Saunders, M., Sargent, D.J., Andre, T., Iveson, T.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6426127/
https://ncbi.nlm.nih.gov/pubmed/29590544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1713709
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars